Back
Miller/Howard High Income Equity Fund Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
72
HIE
Miller/Howard High Income Equity Fund
Last Price:
12.27
Seasonality Move:
-1.63%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
21.00
Seasonality Move:
-9.84%
Buy
72
Miller/Howard High Income Equity Fund (HIE)
is a Buy
Is Miller/Howard High Income Equity Fund a Buy, Sell or Hold?
- The current Miller/Howard High Income Equity Fund [HIE] share price is $12.26. The Score for HIE is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- HIE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $21.51. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HIE Stock Price Chart
What is Miller/Howard High Income Equity Fund's stock price today?
-
The Miller/Howard High Income Equity Fund share price today is $12.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIE is experiencing slight selling pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $21.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight selling pressure.
HIE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 65.57 | Buy |
| Chaikin Money Flow: | -16335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.85 - 12.15) | Buy |
| Bollinger Bands (100): | (11.12 - 11.84) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.8 | Sell |
| Relative Strength Index (14 RSI): | 26.98 | Sell |
| Chaikin Money Flow: | -481436 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.56 - 62.22) | Sell |
| Bollinger Bands (100): | (40.36 - 58.28) | Sell |
HIE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.18 | Buy |
| 20-day SMA: | 12.03 | Buy |
| 50-day SMA: | 11.77 | Buy |
| 200-day SMA: | 11.09 | Buy |
| 8-day EMA: | 12.17 | Buy |
| 20-day EMA: | 12.04 | Buy |
| 50-day EMA: | 11.81 | Buy |
| 200-day EMA: | 11.17 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.47 | Sell |
| 20-day SMA: | 45.29 | Sell |
| 50-day SMA: | 51.84 | Sell |
| 200-day SMA: | 37.33 | Sell |
| 8-day EMA: | 29.4 | Sell |
| 20-day EMA: | 40.5 | Sell |
| 50-day EMA: | 47.43 | Sell |
| 200-day EMA: | 38.91 | Sell |
Miller/Howard High Income Equity Fund Earnings Growth & HIE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
Miller/Howard High Income Equity Fund Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||